Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 32 holding rows worth $7,736,501,045.

Accession
0001104659-25-111932
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 32 entries on the cover page, a total value of $7,736,501,045 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,736,501,045 with VALUE read as dollars as filed, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR5,110,000$1,015,919,100dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock2,022,222$847,735,685dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,833,000$840,723,780dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR990,000$730,184,400dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock2,777,777$490,360,974dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM10,900,000$375,941,000dollars as filed
KYMERA THERAPEUTICS INC501575104COM6,350,000$359,410,000dollars as filed
MERUS N VN5749R100COM3,542,500$333,526,375dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock7,645,000$333,092,650dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM12,222,222$276,588,884dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS10,808,080$262,095,940dollars as filed
UNIQURE NVN90064101SHS4,444,444$259,422,196dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock5,400,000$216,810,000dollars as filed
AKERO THERAPEUTICS INC00973Y108COM3,955,555$187,809,751dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK6,210,000$180,462,600dollars as filed
SOLENO THERAPEUTICS INC834203309COM2,577,777$174,257,725dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY5,155,555$144,355,540dollars as filed
Tourmaline Bio Inc89157D105Common Stock2,555,555$122,232,196dollars as filed
OCULAR THERAPEUTIX INC67576A100COM10,250,000$119,822,500dollars as filed
AMICUS THERAPEUTICS INC03152W109COM15,025,000$118,397,000dollars as filed
89BIO INC282559103COM6,387,790$93,900,513dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK21,700,000$70,959,000dollars as filed
ALKERMES PLCG01767105SHS2,240,000$67,200,000dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock1,333,340$25,640,128dollars as filed
SEPTERNA INC COM81734D104Stock1,337,500$25,158,375dollars as filed
MANNKIND CORP COM NEW56400P706Stock4,468,877$23,997,869dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock2,000,000$14,340,000dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,250,000$9,487,500dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN2,849,402$5,413,864dollars as filed
TANGO THERAPEUTICS INC87583X109COM545,000$4,578,000dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock200,000$4,440,000dollars as filedcall
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY250,000$2,237,500dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-111932this filing2025-11-14acceptance time not in the bulk data set